According to the latest report by IMARC Group, titled “Digital Diabetes Management Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global digital diabetes management market size reached US$ 8.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 29.6 Billion by 2027, exhibiting a growth rate (CAGR) of 22.6% during 2022-2027.

Market Outlook:

Digital diabetes management is an electronic medical solution that uses software-based applications and devices, such as insulin pens, smart glucose meters, closed-loop systems, sensors, and insulin patches. They are largely used for remote monitoring, management, and analysis of patients with diabetes. Diabetes, a metabolic disorder, affects insulin production and leads to elevated blood sugar levels in the body. Digital diabetes management helps manage hyper/hypotension, cholesterol levels, and blood glucose and effectively track and maintain the record of the patients. As a result, they are witnessing a significant demand across at-home or self-care facilities, clinics, hospitals, and research institutes.

Note: We are updating our reports, If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours.

Request to get the sample report: https://www.imarcgroup.com/digital-diabetes-management-market/requestsample

Market Trends: 

The rising prevalence of diabetes has led to an increase in the advent of highly flexible diabetes care solutions, which is majorly driving the global digital diabetes management market growth. In addition to this, the widespread adoption of connected devices and cloud-based enterprise solutions is further fueling the market growth. This is also supported by the inflating sales of smart devices across the globe. Moreover, increasing health consciousness amongst consumers has escalated the demand for blood glucose monitoring devices, which is creating a positive outlook for the market.

Digital Diabetes Management Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the digital diabetes management market has been studied in the report with the detailed profiles of the key players operating in the market.

Major Key Players Covered:

  • Abbott Laboratories (NYSE: ABT)
  • ACON Laboratories Inc
  • Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
  • Becton, Dickinson and Company (NYSE: BDX)
  • Dexcom Inc. (NASDAQ: DXCM)
  • Hoffmann-La Roche AG
  • Medtronic plc (NYSE: MDT)
  • Novo Nordisk A/S (NYSE: NVO)
  • Tandem Diabetes Care Inc. (NASDAQ: TNDM)
  • Terumo Corporation (OTCMKTS: TRUMY)

Key Market Segmentation:

The report has segmented the global digital diabetes management market on the basis of product type, device type and region.

Breakup by Product Type:

  • Smart Glucose Meter
  • Smart Insulin Pumps
  • Smart Insulin Pens
  • Apps

Breakup by Device Type:

  • Handheld Devices
  • Wearable Devices

Geographical Analysis:

  • • North America: (United States, Canada)
    • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
    • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
    • Latin America: (Brazil, Mexico, Others)
    • Middle East and Africa

Explore Report Description with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4081&flag=C

Key Highlights of the Report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About US:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800